Greek

Sign up to the newsletter

Boehringer Ingelheim GmbH

Member: Silver
Since: 06.12.2013

Leoforos Andrea Syngrou 340, 176 73 Kallithea, Greece

RSS

23.03.2021

Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Obesity is a complex cardiometabolic disease with growing global prevalence and limited treatment options that are not sufficiently effective or are associated with adverse events
23.02.2021

Award: Boehringer Ingelheim is Global Top Employer 2021
Boehringer Ingelheim performs particularly well in strategy, corporate culture and employee involvement
12.01.2021

Boehringer Ingelheim partners with PetMedix
Strengthening partnerships to accelerate innovation and growth is now one of the key elements of Boehringer Ingelheim’s refocused strategy
12.01.2021

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
Boehringer Ingelheim has set up a dedicated Quantum Lab with leading experts
21.12.2020

Boehringer Ingelheim: New SARS-CoV-2 Neutralizing Antibody enters Clinical Phase
Virus neutralizing antibodies are expected to become an important line of defense against SARS-CoV-2, complementing vaccines and nonpharmaceutical interventions
MORE